about the product
A cream, containing Argan oil, jojoba oil, virgin pressed cocont oil, shea butter, as well as extracts of everlasting, anchusa strigosa, thyme, saw palmetto and rosemary. No synthetic ingredients whatsever, licensed by Israeli Ministry of Health
Has been used successfully for over 16 years.
Usage: application into the scalp, twice a day. Does not require shampooing after its application (it is water based).
Israeli researchers, Dr. Amir Kitron and Mrs. Rochel Pergamentz, have shown that extracts from local plants which grow under intensive climatic stress, may contain relatively high levels of Brassinosteroids, and that Brassinosteroids help block 5-alpha reductase, which is involved in androgenic alopecia by converting Testosterone to DHDT (as well as in benign prostatic hyperplasia, see drawings below), more powerfully than existing medications such as Propecia, and without the side effects of Propecia (Propecia taken by men can cause impotence and infertility, and is prohibited for women).
This is not a drug; rather, it is a solution for cosmetic use based on extracts from such plants. Such extracts are also present in the conditioner cream, ADIR.
: See also
US Patent number: 8530435
Abstract: Provided are formulations containing brassinosteroids or their derivatives for treating androgen-associated conditions, such as prostate problems. Particularly formulations comprising at least one brassinosteroid or a derivative thereof are provided for treating benign prostatic hyperplasia or androgenic alopecia
Filed: June 2, 2011
Issued: September 10, 2013
Assignee: Grasses of Eden Ltd.
Inventors: Amir Kitron, Rochel Pergamentz
.As shown in this patent, epibrassinolide was 10 times more effective on same molarity basis, than finasteride, in an invitro mode